---
layout: default
title: Glossary
---

# Glossary

| Term                                             | Abbreviation | Reference                          | Definition                                                                                                                                                                                                                                                                                                                                                                     |
|--------------------------------------------------|--------------|------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| **Accessory for a Medical Device**               | -            | MDR Article 2(2)                   | Article enabling specific medical device use or directly assisting its functionality.                                                                                                                                                                                                                                                |
| **Active Device**                                | -            | MDR Article 2(4)                   | Device depending on an external energy source, acting by converting that energy. Software is also considered an active device.                                                                                                                                                                                                        |
| **Administration by Inhalation**                 | -            |                    | Inhalation solutions for respiratory treatment, dissolved in solvent, locally acting, some with systemic effects. Requires nebulization or vaporization.                                                                                                                                                                               |
| **Agglomerate**                      | -            | MDR Article 2(20)| Collection of weakly bound particles where the resulting surface area is close to the sum of surface areas of individual particles.                            |
| **Aggregate**                        | -            | MDR Article 2(21)| Particle comprising strongly bound or fused particles.                                                                                                        |
| **Authorised Representative**                    | AR           | MDR Article 2(32)                  | Natural/legal person within the EU mandated by a non-EU manufacturer to act on their behalf for regulatory obligations.                                                                                                                                                                                                                |
| **Benefit-Risk Determination**       | -            | MDR Article 2(24)| Analysis of all assessments of benefits and risks relevant for the device’s use for its intended purpose.                                                    |
| **Body Orifice**                                 | -            | MDR Annex VIII 2.1                 | Natural opening, external surface of the eyeball, or surgically created permanent opening (e.g., stoma).                                                                                                                                                                                                                                |
| **CE Marking**                                   | -            | MDR Article 20                     | Marking indicating compliance with MDR and other applicable Union legislation.                                                                                                                                                                                                                                                        |
| **CE Marking of Conformity**         | -            | MDR Article 2(43)| Marking indicating that a device complies with MDR and other applicable Union legislation.                                                                  |
| **Clinical Evaluation**                          | -            | MDR Article 2(44)                  | Systematic process to collect, analyse, and assess clinical data to verify safety and performance, including benefits.                                                                                                                                                                                                                  |
| **Clinical Investigation**                       | -            | MDR Article 2(45)                  | Systematic investigation involving human subjects to assess safety and performance.                                                                                                                                                                                                                                                    |
| **Compatibility**                    | -            | MDR Article 2(25)| Ability of a device to perform with other devices without losing performance or requiring modification.                                                       |
| **Conformity Assessment**                        | -            | MDR Article 2(40)                  | Process demonstrating fulfillment of MDR requirements.                                                                                                                                                                                                                                                                                 |
| **Conformity Assessment Body**       | -            | MDR Article 2(41)| Body performing third-party conformity assessment activities such as calibration, testing, certification, and inspection.                                     |
| **Custom-Made Device**                           | -            | MDR Article 2(3)                   | Device made for a specific patient based on professional prescription, with specific design features.                                                                                                                                                                                                                                   |
| **Derivative**                                   | -            | MDR Article 2(17)                  | Non-cellular substance extracted from human/animal tissue or cells via manufacturing process, free of cells/tissues.                                                                                                                                                                                                                    |
| **Distributor**                                  | -            | MDR Article 2(34)                  | Natural/legal person making devices available on the market up to the point of putting into service.                                                                                                                                                                                                                                    |
| **Directive 2001/83/EC**                 | -            | Directive 2001/83/EC       | Establishes a Community code relating to medicinal products for human use. |
| **Economic Operator**                            | -            | MDR Article 2(35)                  | Manufacturer, authorised representative, importer, distributor, or Article 22(1)/(3) entity.                                                                                                                                                                                                                                           |
| **Efficacy (of a Medicinal Product)**            | -            |                   | Ability of a procedure/substance to causally induce a predefined change (biochemical processes, cells, tissues, organisms).                                                                                                                                                                                                            |
| **EUDAMED**                                      | -            | MDR Article 33                     | EU database integrating systems on devices, operators, certificates, clinical investigations, and vigilance.                                                                                                                                                                                                                            |
| **Falsified Device**                 | -            | MDR Article 2(9) | Any device with false presentation of identity, source, or CE marking certificates/documents, excluding unintentional non-compliance.                         |
| **Field Safety Corrective Action**               | FSCA         | MDR Article 2(68)                  | Corrective action by manufacturer to prevent or reduce serious incident risk for a marketed device.                                                                                                                                                                                                                                     |
| **Field Safety Notice**                          | FSN          | MDR Article 2(69)                  | Communication from manufacturer to users/customers about a field safety corrective action.                                                                                                                                                                                                                                             |
| **General Safety and Performance Requirements**  | GSPR         | MDR Annex I                        | Core requirements ensuring health and safety protection.                                                                                                                                                                                                                                                                                |
| **Generic Device Group**             | -            | MDR Article 2(7) | Set of devices with the same or similar intended purpose or commonality of technology, allowing them to be classified in a generic way without reflecting specific characteristics. |
| **Health Institution**               | -            | MDR Article 2(36)| Organisation whose primary purpose is care or treatment of patients or promotion of public health.                                                           |
| **Implantable Device**               | -            | MDR Article 2(5) | Any device, including those partially or wholly absorbed, intended to be totally or partially introduced into the human body or natural orifice by clinical intervention and intended to remain after the procedure. |
| **Importer**                                     | -            | MDR Article 2(33)                  | Natural/legal person placing a third-country device on the EU market.                                                                                                                                                                                                                                                                  |
| **Immunological Mechanism**                      | -            | MDR Annex VIII 1.4                 | Mode of action through stimulation/mobilisation of cells/products involved in immune response.                                                                                                                                                                                                                                          |
| **Inhalation**                                   | -            |                   | Inhalation of gases or aerosols.                                                                                                                                                                                                                                                                                                       |
| **Instructions for Use**             | -            | MDR Article 2(14)| Information provided by the manufacturer to inform users of the device’s intended purpose, proper use, and necessary precautions.                            |
| **Intended Purpose**                 | -            | MDR Article 2(12)| Use specified by the manufacturer on labels, instructions for use, or promotional materials, and in clinical evaluation.                                      |
| **Internal Exposure**                            | -            | MDR Recital 15                     | Proportion of original dose absorbed and distributed via bloodstream.                                                                                                                                                                                                                                                                  |
| **Invasive Device**                  | -            | MDR Article 2(6) | Any device which, in whole or in part, penetrates inside the body, either through a body orifice or through the surface of the body.                           |
| **Intact Skin**      | -            | Provided by user | Skin that is not damaged or injured. |
| **Interoperability**                 | -            | MDR Article 2(26)| Ability of devices (including software) to exchange and use information for correct execution of a specified function.                                       |
| **Label**                            | -            | MDR Article 2(13)| Written, printed, or graphic information appearing on the device, packaging, or grouped packaging.                                                            |
| **Lay Person**                       | -            | MDR Article 2(38)| Individual without formal education in a relevant healthcare or medical discipline.                                                                         |
| **Long-Term Use**            | -            | MDR Annex VIII Chapter 1 | Intended for continuous use for more than 30 days under normal conditions.                                                                                                                                                                                                                   |
| **Making Available on the Market**   | -            | MDR Article 2(27)| Supply of a device, other than an investigational device, for distribution, consumption, or use on the Union market in the course of a commercial activity.   |
| **Manufacturer**                                 | -            | MDR Article 2(30)                  | Person manufacturing/refurbishing a device and placing it on the market under their name or trademark.                                                                                                                                                                                                                                  |
| **Medical Device**                               | -            | MDR Article 2(1)                   | Instrument, software, implant, etc., for diagnosis, prevention, monitoring, treatment, etc., acting primarily through non-pharmacological, non-immunological, non-metabolic means.                                                                                                                                                      |
| **Medicinal Product**                            | -            | Directive 2001/83/EC Article 1(2)  | Substance or combination for treating/preventing disease, or restoring/correcting/modifying physiological functions through pharmacological, immunological, or metabolic action, or for diagnosis.                                                                                                                                        |
| **Metabolic Mechanism**                          | -            | MDR Annex VIII 1.4                 | Mode of action modifying (initiating, interrupting, altering) normal chemical processes.                                                                                                                                                                                                                                                |
| **Metabolite**                                   | -            |                   | Intermediate product in a biochemical metabolic process.                                                                                                                                                                                                                                                                                |
| **Nanomaterial**                                 | -            | MDR Article 2(18)                  | Natural/incidental/manufactured material with ≥50% particles between 1-100 nm; includes fullerenes, graphene flakes, single-walled carbon nanotubes <1 nm.                                                                                                                                                                               |
| **Non-Viable**                       | -            | MDR Article 2(16)| Having no potential for metabolism or multiplication.                                                                                                         |
| **Notified Body**                                | -            | MDR Article 2(42)                  | Conformity assessment body designated under MDR.                                                                                                                                                                                                                                                                                       |
| **Particle**                         | -            | MDR Article 2(19)| Minute piece of matter with defined physical boundaries.                                                                                                      |
| **Performance**                      | -            | MDR Article 2(22)| Ability of a device to achieve its intended purpose as stated by the manufacturer.                                                                            |
| **Person Responsible for Regulatory Compliance** | PRRC         | MDR Article 15                     | Qualified person ensuring regulatory compliance within a manufacturer.                                                                                                                                                                                                                                                                  |
| **Pharmacological Mechanism**                    | -            | MDR Annex VIII 1.4                 | Mode of action involving interaction between substance molecules and cellular components (e.g., receptors), triggering/blocking responses.                                                                                                                                                                                               |
| **Placing on the Market**                        | -            | MDR Article 2(28)                  | First making available of a device (not investigational) on the Union market.                                                                                                                                                                                                                                                            |
| **Procedure Pack**                   | -            | MDR Article 2(10)| Combination of products packaged together for use for a specific medical purpose.                                       |
| **Post-Market Surveillance**                     | PMS          | MDR Article 2(60)                  | All activities by manufacturers and operators to proactively collect and review device performance and safety data to identify and apply corrective/preventive actions.                                                                                                                                                                  |
| **Potential (high/medium)**                      | -            | MDR Recital 15                     | Products with nanoparticles having high/medium internal exposure potential should undergo strictest conformity assessment procedures.                                                                                                                                                                                                   |
| **Putting into Service**                         | -            | MDR Article 2(29)                  | Device made available to final user as ready for use in the EU for the first time.                                                                                                                                                                                                                                                       |
| **Risk**                             | -            | MDR Article 2(23)| Combination of the probability of occurrence of harm and the severity of that harm.                                                                           |
| **Reprocessing**                     | -            | MDR Article 2(39)| Process carried out on a used device to allow safe reuse, including cleaning, disinfection, sterilisation, and testing.                                       |
| **Serious Incident**                             | -            | MDR Article 2(64)                  | Incident leading to death, serious deterioration of health, or serious public health threat.                                                                                                                                                                                                                                             |
| **Single-Use Device**                            | -            | MDR Article 2(8)                   | Device intended for use on one individual during a single procedure.                                                                                                                                                                                                                                                                     |
| **Substances**                                   | -            | MEDDEV 2.1/3 rev3                  | Substances achieving intended effect through physico-chemical or physical means, excluding pharmacological, immunological, or metabolic actions.                                                                                                                                                                                         |
| **System**                           | -            | MDR Article 2(11)| Combination of products, either packaged together or not, intended to be interconnected or combined to achieve a specific medical purpose.                   |
| **Systemic**                                     | -            |                 | Absorption into blood/lymphatic system for distribution throughout the body.                                                                                                                                                                                                                                                             |
| **Unique Device Identifier**                     | UDI          | MDR Article 27                     | Device identification and traceability system using globally accepted standards.                                                                                                                                                                                                                                                         |
| **User**                             | -            | MDR Article 2(37)| Any healthcare professional or lay person who uses a device.                                                                                                  |
| **Vigilance**                                    | -            | MDR Article 2(58)                  | Activities to collect, analyze, and respond to information on adverse events and device problems to minimize risk.                                                                                                                                                                                                                       |
| **X-ray Radiation**     | -            | Provided by user | X-rays are electromagnetic waves with photon energy higher than that of ultraviolet light. |

### References
- [EU MDR Full Text](https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32017R0745)
- [MDCG Guidance Documents](https://health.ec.europa.eu/medical-devices-sector/new-regulations/guidance-mdcg-endorsed-documents-and-other-guidance_en)
- [ISO 14971 - Risk Management](https://www.iso.org/standard/72704.html)
- [ISO 13485 - Quality Management](https://www.iso.org/standard/59752.html)
